Biomarkers, breast density and risk reduction perspectives in BRCA carriers.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Deslorelin (Primary) ; Estradiol (Primary) ; Testosterone (Primary)
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 13 Jul 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
- 12 Jul 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Sep 2017.
- 29 Jun 2015 Status changed from completed to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.